Food And Drug Administration Approves Brand Brand New Libido-Boosting Drug for Premenopausal Females

Food And Drug Administration Approves Brand Brand New Libido-Boosting Drug for Premenopausal Females

The usa Food and Drug management (Food And Drug Administration) today authorized bremelanotide (Vyleesi, AMAG Pharmaceuticals), a first-in-class melanocortin 4 receptor agonist for hypoactive sexual interest disorder (HSDD) in premenopausal ladies.

It joins flibanserin (Addyi, Sprout Pharmaceuticals), the sole other HSDD that is FDA-approved treatment premenopausal ladies. Leer más